BioAmber Inc. is a sustainable chemicals company. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into building block chemicals for use in a wide variety of everyday products including plastics, resins, food additives and personal care products. BioAmber has been listed on the New York Stock Exchange since May 2013, under the symbol BIOA. BioAmber is a Delaware corporation with a head office in Montreal, Quebec, Canada, a research facility in St. Paul (Minneapolis), Minnesota, and a commercial plant operating in Sarnia, Ontario, Canada. BioAmber’s investors include Sofinnova Partners (France), Naxos Capital Partners (Luxemburg), Mitsui & Co. (Japan), LANXESS (Germany) and the Cliffton Group (Canada). BioAmber was established in 2008 as a result of a spin-off from New York-based Diversified Natural Products (DNP). The company was originally named DNP Green Technology and was based in Princeton, New Jersey. Prior to the spin-off, DNP had established a joint venture with France-based Agro-Industrie Recherches et Développements (ARD). The goal of the joint venture was to develop and commercialize bio-based succinic acid, and the JV was named BioAmber. In 2010, DNP Green Technology acquired 100 percent of the joint venture from ARD and changed its corporate name to BioAmber. After the Company was spun off from DNP, it was privately financed in 2009 by a group of institutional investors led by Sofinnova Partners, Mitsui & Co., Samsung Ventures and the Cliffton Group. In 2011 and 2012, Naxos Capital Partners and Lanxess became investors in the Company, which raised a total of $87 million over three rounds of financing between 2009 and 2012. In May 2013, BioAmber completed its initial public offering on the New York Stock Exchange under the symbol BIOA, raising $80 million in gross proceeds and issuing warrants for an additional $44 million in common stock.